Summary
The product Prime Ripped 150 mg/ml, manufactured by PrimePharma, underwent rigorous testing to verify its authenticity and potency. The sample, identified by batch number PP1784, was submitted by the reseller Opitropin.EU and analyzed by Janoshik Analytical, a laboratory with a focus on pharmaceutical quality control. The analysis measured the presence of three active compounds: Drostanolone Propionate (54.97 mg/ml), Trenbolone Acetate (47.62 mg/ml), and Testosterone Propionate (53.77 mg/ml). This totals a concentration of 156.36 mg/ml, exceeding the labeled claim of 150 mg/ml by 4.24%.
The testing process began on 2 May 2023, with the sample received on 11 May 2023, and analysis completed on 15 May 2023. Reseller-submitted testing, such as this, requires careful scrutiny due to potential biases, including batch selection. While the results confirm accurate dosing, independent third-party testing is recommended to ensure consistency across batches. This report is provided to support harm reduction and educational efforts for informed decision-making.
Detailed Report
Product Overview
- Manufacturer: PrimePharma
- Product Name: Prime Ripped 150 mg/ml
- Active Ingredients:
- Drostanolone Propionate
- Trenbolone Acetate
- Testosterone Propionate
- Batch Number: PP1784
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #29400
- Testing Ordered: 2 May 2023
- Sample Received: 11 May 2023
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Specification: 150 mg/ml (as stated on the label)
- Measured Concentration:
- Drostanolone Propionate: 54.97 mg/ml
- Trenbolone Acetate: 47.62 mg/ml
- Testosterone Propionate: 53.77 mg/ml
- Total Concentration: 156.36 mg/ml
- Accuracy: 104.24% (4.24% above the label claim)
Verification Details:
- Verification URL: https://janoshik.com/tests/29400_XU5A2BI51JHW
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
This report, funded and submitted by the reseller Opitropin.EU, highlights the need for caution when interpreting such results. Resellers may select batches that are likely to meet specifications, raising concerns about the consistency of products available to consumers. While Janoshik Analytical has a reputation for transparency and reliability, additional independent third-party testing would enhance consumer confidence in these findings.
The results indicate a slight overdosage relative to the labeled specification, suggesting quality manufacturing practices for this batch. However, testing across multiple batches would provide a more comprehensive picture of product reliability and consistency.
Conclusion
The analysis confirms that Prime Ripped 150 mg/ml contains slightly more active compounds than claimed, with a total measured concentration of 156.36 mg/ml. This result demonstrates quality manufacturing practices but underscores the importance of independent validation to ensure consistent dosing across all batches. This report serves as an educational resource for harm reduction, helping users make informed decisions about anabolic steroid products.
Disclaimer: This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
